Hwan‐Jung Yun

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text

Medicine, Hematology, Oncology +12

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 210 citations · Full text

Medicine, Oncology, Pharmacology +16

A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes

Seungtaek Lim, Hyun Chang, M.J. Yoon et al. · Annals of Oncology · 2013 · 141 citations · Full text

Medicine, Oncology, Pharmacology +15

A Comparative Trial of a Single Dose of Azithromycin versus Doxycycline for the Treatment of Mild Scrub Typhus

Kim Ys, Hwan‐Jung Yun, Soo Kyoung Shim et al. · Clinical Infectious Diseases · 2004 · 139 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +8

Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus

H.-Y. Lee, Yeon-Sik Hong, Hwan‐Jung Yun et al. · Lara D. Veeken · 2008 · 114 citations · Full text

Life Sciences, Cell Biology, Immunology +17